Swiss National Bank Exact Sciences Corp Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Exact Sciences Corp stock. As of the latest transaction made, Swiss National Bank holds 547,680 shares of EXAS stock, worth $27.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

547,680

Previous 535,080 2.35%

Holding current value

$27.9 Million

Previous $22.6 Million 64.95%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$42.43 - $70.83 $534,618 - $892,458	12,600 Added 2.35%	547,680 $37.3 Million
Q2 2024 Aug 08, 2024	SELL	$41.33 - $74.26 $268,645 - $482,690	-6,500 Reduced 1.2%	535,080 $22.6 Million
Q1 2024 May 07, 2024	SELL	$56.27 - $73.77 $1.32 Million - $1.73 Million	-23,400 Reduced 4.14%	541,580 $37.4 Million
Q4 2023 Feb 06, 2024	SELL	$59.06 - $75.72 $903,618 - $1.16 Million	-15,300 Reduced 2.64%	564,980 $41.8 Million
Q3 2023 Nov 08, 2023	SELL	$65.94 - $99.04 $4.17 Million - $6.26 Million	-63,200 Reduced 9.82%	580,280 $39.6 Million
Q2 2023 Aug 09, 2023	SELL	$62.68 - $95.05 $3.75 Million - $5.69 Million	-59,900 Reduced 8.52%	643,480 $60.4 Million
Q1 2023 May 10, 2023	SELL	$47.19 - $70.77 $745,602 - $1.12 Million	-15,800 Reduced 2.2%	703,380 $47.7 Million
Q4 2022 Feb 08, 2023	SELL	$30.35 - $53.15 $1.31 Million - $2.3 Million	-43,237 Reduced 5.67%	719,180 $35.6 Million
Q3 2022 Nov 09, 2022	BUY	$31.97 - $49.37 $226,987 - $350,527	7,100 Added 0.94%	762,417 $24.8 Million
Q2 2022 Aug 09, 2022	BUY	$35.61 - $76.23 $316,929 - $678,447	8,900 Added 1.19%	755,317 $29.8 Million
Q1 2022 May 09, 2022	BUY	$57.56 - $82.54 $5.34 Million - $7.66 Million	92,800 Added 14.2%	746,417 $52.2 Million
Q4 2021 Feb 08, 2022	SELL	$72.5 - $100.68 $1.78 Million - $2.47 Million	-24,500 Reduced 3.61%	653,617 $50.9 Million
Q3 2021 Nov 08, 2021	SELL	$90.24 - $124.05 $1.04 Million - $1.43 Million	-11,500 Reduced 1.67%	678,117 $64.7 Million
Q2 2021 Aug 06, 2021	BUY	$93.66 - $139.27 $7.3 Million - $10.9 Million	77,993 Added 12.75%	689,617 $85.7 Million
Q1 2021 May 07, 2021	BUY	$116.57 - $155.01 $1.4 Million - $1.86 Million	12,000 Added 2.0%	611,624 $80.6 Million
Q4 2020 Feb 05, 2021	BUY	$99.61 - $142.12 $1.66 Million - $2.37 Million	16,700 Added 2.86%	599,624 $79.4 Million
Q3 2020 Nov 09, 2020	SELL	$72.92 - $102.01 $160,424 - $224,422	-2,200 Reduced 0.38%	582,924 $59.4 Million
Q2 2020 Aug 05, 2020	BUY	$55.75 - $92.75 $864,125 - $1.44 Million	15,500 Added 2.72%	585,124 $50.9 Million
Q1 2020 May 08, 2020	BUY	$37.9 - $104.44 $4.12 Million - $11.4 Million	108,700 Added 23.58%	569,624 $33 Million
Q4 2019 Feb 06, 2020	BUY	$77.66 - $99.74 $2.68 Million - $3.44 Million	34,480 Added 8.09%	460,924 $42.6 Million
Q3 2019 Nov 12, 2019	BUY	$90.37 - $122.49 $1.49 Million - $2.01 Million	16,444 Added 4.01%	426,444 $38.5 Million
Q2 2019 Aug 02, 2019	BUY	$89.51 - $118.04 $16.7 Million - $22 Million	186,081 Added 83.1%	410,000 $48.4 Million
Q1 2019 May 10, 2019	BUY	$61.98 - $96.5 $427,662 - $665,850	6,900 Added 3.18%	223,919 $19.4 Million
Q4 2018 Feb 13, 2019	BUY	$56.04 - $82.66 $246,576 - $363,704	4,400 Added 2.07%	217,019 $13.7 Million
Q3 2018 Nov 08, 2018	BUY	$48.29 - $80.6 $96,580 - $161,200	2,000 Added 0.95%	212,619 $16.8 Million
Q2 2018 Aug 09, 2018	BUY	$37.84 - $69.96 $113,520 - $209,879	3,000 Added 1.44%	210,619 $12.6 Million
Q1 2018 May 04, 2018	BUY	$39.82 - $57.53 $191,136 - $276,144	4,800 Added 2.37%	207,619 $8.37 Million
Q4 2017 Feb 07, 2018	BUY	$46.49 - $60.51 $283,589 - $369,111	6,100 Added 3.1%	202,819 $10.7 Million
Q3 2017 Nov 03, 2017	BUY	$37.05 - $47.12 $7.29 Million - $9.27 Million	196,719	196,719 $9.27 Million

Others Institutions Holding EXAS

# of Institutions

666

Shares Held

162M

Call Options Held

2.32M

Put Options Held

1.68M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.01B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Exact Sciences Corp Transaction History